Literature DB >> 25856784

Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial.

Klaas M Huijbregts1, Neeltje M Batelaan, Judy Schonenberg, Gerthe Veen, Anton J van Balkom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25856784     DOI： 10.1097/JCP.0000000000000313

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Sleep, Circadian Rhythms, and Anxious Traits.

Authors:  Meredith E Coles; Jessica R Schubert; Jacob A Nota
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

2.  Functional neuroanatomy in panic disorder: Status quo of the research.

Authors:  Thomas Sobanski; Gerd Wagner
Journal:  World J Psychiatry       Date:  2017-03-22

Review 3.  Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review.

Authors:  Patrícia Santos; Ana P Herrmann; Elaine Elisabetsky; Angelo Piato
Journal:  Braz J Psychiatry       Date:  2018-10-11       Impact factor: 2.697

Review 4.  Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.

Authors:  Josiel Mileno Mack; Marissa Giovanna Schamne; Tuane Bazanella Sampaio; Renata Aparecida Nedel Pértile; Pedro Augusto Carlos Magno Fernandes; Regina P Markus; Rui Daniel Prediger
Journal:  Oxid Med Cell Longev       Date:  2016-10-18       Impact factor: 6.543

Review 5.  Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders.

Authors:  Yong-Ku Kim; Sang Won Jeon
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.